NK cells in breast cancer. Andréa Massidda
Trends Immunol. 2026 Aug 13:S1471-4906(26)00186-9. doi: 10.1016/j.it.2026.07.007. Online ahead of print. ABSTRACT Natural killer (NK) cells are effectors of innate antitumor immunity, yet their therapeutic potential in solid tumors remains largely unrealized. Breast cancer exemplifies this paradox: NK cells are present in circulation and detectable within tumors, but their cytotoxic activity is limited. Recent advances … Read more